NI201800043A - Nuevos derivados de imidazo[4,5-b]piridina como inhibidores duales de dyrk1/clk1 - Google Patents

Nuevos derivados de imidazo[4,5-b]piridina como inhibidores duales de dyrk1/clk1

Info

Publication number
NI201800043A
NI201800043A NI201800043A NI201800043A NI201800043A NI 201800043 A NI201800043 A NI 201800043A NI 201800043 A NI201800043 A NI 201800043A NI 201800043 A NI201800043 A NI 201800043A NI 201800043 A NI201800043 A NI 201800043A
Authority
NI
Nicaragua
Prior art keywords
dyrk1
clk1
imidazo
pyridine
new derivatives
Prior art date
Application number
NI201800043A
Other languages
English (en)
Inventor
Bálint BALÁZS
Kotschy ANDRÁS
Sipos Melinda
Wéber Csaba
Foloppe Nicolas
Walmsley David
Frank Burbridge Michaël
Humberto CRUZALEGUI Francisco
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NI201800043A publication Critical patent/NI201800043A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

(Fórmula I) Compuestos de fórmula (I): útiles para el tratamiento de cáncer, trastornos neurodegenerativos y trastornos metabólicos.
NI201800043A 2015-09-30 2018-03-23 Nuevos derivados de imidazo[4,5-b]piridina como inhibidores duales de dyrk1/clk1 NI201800043A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1559252A FR3041639B1 (fr) 2015-09-30 2015-09-30 NOUVEAUX DERIVES D'IMIDAZO[4,5-b]PYRIDINE, PROCEDE POUR LES PREPARER ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT

Publications (1)

Publication Number Publication Date
NI201800043A true NI201800043A (es) 2018-06-21

Family

ID=54979755

Family Applications (1)

Application Number Title Priority Date Filing Date
NI201800043A NI201800043A (es) 2015-09-30 2018-03-23 Nuevos derivados de imidazo[4,5-b]piridina como inhibidores duales de dyrk1/clk1

Country Status (26)

Country Link
US (1) US20180273528A1 (es)
EP (1) EP3356363A1 (es)
JP (1) JP2018535931A (es)
KR (1) KR20180054858A (es)
CN (1) CN108137581A (es)
AU (1) AU2016333505A1 (es)
BR (1) BR112018006157A2 (es)
CA (1) CA2999935A1 (es)
CL (1) CL2018000783A1 (es)
CO (1) CO2018003473A2 (es)
CR (1) CR20180181A (es)
CU (1) CU20180028A7 (es)
DO (1) DOP2018000083A (es)
EA (1) EA201890821A1 (es)
EC (1) ECSP18023253A (es)
FR (1) FR3041639B1 (es)
HK (1) HK1255804A1 (es)
IL (1) IL258341A (es)
MA (1) MA43020A (es)
MX (1) MX2018003860A (es)
NI (1) NI201800043A (es)
PE (1) PE20181331A1 (es)
PH (1) PH12018500650A1 (es)
SV (1) SV2018005657A (es)
TN (1) TN2018000090A1 (es)
WO (1) WO2017055530A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108822103A (zh) * 2018-07-28 2018-11-16 刘凤娟 一种咪唑并[4,5-b]吡啶化合物及其制备方法和应用
CN113164476A (zh) * 2018-09-28 2021-07-23 代表亚利桑那大学的亚利桑那校董会 Dyrk1/clk的小分子抑制剂及其用途
WO2020092528A1 (en) 2018-10-31 2020-05-07 Gilead Sciences, Inc. Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity
US11203591B2 (en) 2018-10-31 2021-12-21 Gilead Sciences, Inc. Substituted 6-azabenzimidazole compounds
EP3972695A1 (en) 2019-05-23 2022-03-30 Gilead Sciences, Inc. Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors
CA3153531A1 (en) * 2019-09-11 2021-03-18 Prelude Therapeutics Incorporated Cdk inhibitors and their use as pharmaceuticals

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016516710A (ja) * 2013-03-13 2016-06-09 アッヴィ・インコーポレイテッド ピリジン系ｃｄｋ９キナーゼ阻害薬

Also Published As

Publication number Publication date
DOP2018000083A (es) 2018-10-15
CR20180181A (es) 2018-06-22
MX2018003860A (es) 2018-08-16
US20180273528A1 (en) 2018-09-27
CL2018000783A1 (es) 2018-09-21
CN108137581A (zh) 2018-06-08
AU2016333505A1 (en) 2018-04-19
TN2018000090A1 (en) 2019-07-08
ECSP18023253A (es) 2018-04-30
JP2018535931A (ja) 2018-12-06
CA2999935A1 (en) 2017-04-06
PE20181331A1 (es) 2018-08-20
SV2018005657A (es) 2018-07-31
CU20180028A7 (es) 2018-07-05
EA201890821A1 (ru) 2018-10-31
KR20180054858A (ko) 2018-05-24
PH12018500650A1 (en) 2018-10-01
EP3356363A1 (en) 2018-08-08
BR112018006157A2 (pt) 2018-10-09
FR3041639A1 (es) 2017-03-31
IL258341A (en) 2018-05-31
CO2018003473A2 (es) 2018-07-10
WO2017055530A1 (en) 2017-04-06
FR3041639B1 (fr) 2019-01-25
MA43020A (fr) 2018-08-08
HK1255804A1 (zh) 2019-08-23

Similar Documents

Publication Publication Date Title
NI201800042A (es) Nuevos derivados de pirrolo[2,3-d]pirimidina como inhibidores duales de dyrk1/clk1
PH12019501321B1 (en) Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disorders
ECSP19003773A (es) Compuestos heterocíclicos como inmunomoduladores
NI201800043A (es) Nuevos derivados de imidazo[4,5-b]piridina como inhibidores duales de dyrk1/clk1
CO2017007663A2 (es) Derivados de 4h-pirrol[3,2-c]piridin-4-ona
CL2016002735A1 (es) Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso para tratar cáncer
DK3322706T3 (da) Substituerede pyrazolo[1,5-a]pyridin-forbindelser som ret-kinaseinhibitorer
UY34657A (es) ?derivados macrocíclicos para el tratamiento de enfermedades?.
CL2014002412A1 (es) Compuestos derivados de pirido[4,3-d]pirimidina, como inhibidores de mek; composicion farmaceutica que los comprende; y su uso para el tratamiento de enfermedades inflamatorias, infecciones, trastornos autoinmunes, enfermedades metabolicas y enfermedades malignas, entre otras.
PH12015502248B1 (en) 6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide derivatives and their use as phd inhibitors
DK2922828T3 (da) 4,6-diamino-pyrimidin-derivater som bmi-1-inhibitorer til at behandle cancer
HK1247923A1 (zh) 可用作哺乳動物酪氨酸激酶ror1活性抑制劑的2-苯基-3h-咪唑並[4，5-b]吡啶衍生物
CL2016000496A1 (es) Compuestos derivados de 1,2,4-triazolo[1,5-a]-piridina, inhibidores de una janus cinasa, tal como jak1; composiciones farmacológicas; útiles para el tratamiento de enfermedades inflamatorias.
MX2016008042A (es) Derivados de imidazopirazinona.
JO3372B1 (ar) مشتقات 5-بنزيل إيزوكينولين لعلاج أمراض القلب والأوعية الدموية
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
WO2014113407A3 (en) Use of small molecule inhibitors targeting eya tyrosine phosphatase
DK3083627T3 (da) [1,2,4]triazol[1,5-a]pyrimidinderivater som protozoiske proteasominhibitorer til behandling af parasitsygdomme, såsom leishmaniasis
EA201791099A1 (ru) Хинолин карбоксамиды для применения в лечении лейкоза
EP3694521A4 (en) TOPICAL METHOTREXATE SOLUTION FOR TREATMENT OF PSORIASIS
EA201892188A1 (ru) Соединения пирролотриазина в качестве ингибиторов tam
AR101915A1 (es) Intermediarios y procesos para la preparación de compuestos